Safety, Efficacy of Dimethyl Fumarate for Multiple Sclerosis in Minority Groups
Black/African American and Hispanic/Latino patients with multiple sclerosis saw a treatment benefit with dimethyl fumarate.
Stay updated with breaking news from Multiple Sclerosis Centers. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Black/African American and Hispanic/Latino patients with multiple sclerosis saw a treatment benefit with dimethyl fumarate.
Inebilizumab is effective for neuromyelitis optica spectrum disorder, even among patients who are genetically at risk for reduced response to anti-CD20 therapies, new research suggests.
Among patients with highly active relapsing MS, use of ublituximab led to improvement in cognitive processing speed at 96 weeks compared with teriflunomide.
Nabiximols has a significant treatment effect on spasticity in patients with MS who are either being treated with or without antispasticity medications.
Over 25 years of clinical research, phase 3 trials of approved disease-modifying therapies for multiple sclerosis were overwhelmingly made up of White participants, new research shows.